UOC
LUXAW

UBS O'Connor’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

UBS O'Connor’s Portfolio LUXAW Stock Details LUXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-87,168
Closed -$36K – 1080
2022
Q1 		$36K Buy
87,168
+1,542
+2% +$876 ﹤0.01% 917
2021
Q4 		$73K Buy
85,626
+2,296
+3% +$2.52K ﹤0.01% 878
2021
Q3 		$97K Hold
83,330
– – ﹤0.01% 828
2021
Q2 		$112K Hold
83,330
– – ﹤0.01% 814
2021
Q1 		$122K Buy
+83,330
New +$210K ﹤0.01% 733

Other funds holding LUXAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
WH
Wolfswood Holdings New York $4.36M AUM 48.32% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BP
BBR Partners New York $2.13B AUM 21.87% 1-Year Est. Return

UBS O'Connor's LUXAW Position: Q2 2022 in Review

UBS O'Connor sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q2 2022, closing a stake of 87,168 shares — an estimated $36K sold.

UBS O'Connor first reported a position in LUXAW in Q1 2021 and held it in 5 quarters. The position peaked at $122K in Q1 2021. 29 funds tracked by Wall St. Rank hold LUXAW as of Q2 2022.

  • UBS O'Connor reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 87,168 Lux Health Tech Acquisition Corp. Warrants shares in Q2 2022, an estimated $36K.
  • UBS O'Connor first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 5 quarters.
  • UBS O'Connor's Lux Health Tech Acquisition Corp. Warrants position peaked at $122K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.